期刊文献+

盐酸文拉法辛渗透泵型缓释片人体药动学特性 被引量:2

Study on pharmacokinetics of osmotic pump tablets of hydrochloride venlafaxine in Chinese healthy volunteers
下载PDF
导出
摘要 目的比较餐后状态下两种盐酸文拉法辛缓释片在中国健康受试者体内药动学及生物等效性。方法本试验入组26例受试者,采用随机、开放、两周期、两序列、双交叉给药设计,单次口服受试或参比制剂(75 mg)后,运用LC-MS/MS测定血浆中文拉法辛(VEN)及其活性代谢产物O-去甲基文拉法辛(ODV)浓度,经PhoenixTM WinNonlin 6.4软件计算药动学参数,以VEN的药动学参数作为评价指标,ODV作为参考,进行生物等效性分析。结果餐后服用受试或参比制剂后,血浆VEN的Cmax分别为(58.50±19.47)和(60.14±22.18)μg·L^(-1),AUC0-t分别为(1074.1±526.7)和(1057.9±539.7)μg·h·L^(-1),AUC0-∞分别为(1084.7±536.8)和(1067.8±554.0)μg·h·L^(-1);ODV的Cmax分别为(101.63±29.64)和(101.45±31.62)μg·L^(-1),AUC0-t分别为(2694.0±834.5)和(2702.9±946.4)μg·h·L^(-1),AUC0-∞分别为(2753.9±885.5)和(2753.2±988.4)μg·h·L^(-1),VEN和ODV的Cmax,AUC0-t,AUC0-∞几何均数比值90%CI均在80.00%~125.00%等效区间内。结论餐后状态下,两制剂在中国健康受试者体内具有生物等效性。 Aim To evaluate the pharmacokinetics and bioequivalence of two osmotic pump tablets of hydrochloride venlafaxine in Chinese healthy volunteers.Methods The fed test each enrolled twenty-six Chinese healthy volunteers in a randomized-sequence,open-label,two-period crossover single-dose oral test and reference preparations of hydrochloride venlafaxine extended-release tablets.The plasma concentrations of venlafaxine and its active metabolites O-desmethylvenlafaxine were determined by a validated liquid chromatography-tandem mass spectrometry(LC-MS/MS)method,and the pharmacokinetic parameters and bioequivalence of the two tablets were analyzed using PhoenixTM WinNonlin 6.4 software.Results The pharmacokinetic parameters of venlafaxine after single dose for the test and reference tablets were as follows:Cmax(58.50±19.47)vs(60.14±22.18)μg·L^(-1),AUC0-t(1074.1±526.7)vs(1057.9±539.7)μg·h·L^(-1),AUC0-∞(1084.7±536.8)vs(1067.8±554.0)μg·h·L^(-1).The pharmacokinetic parameters of O-desmethylvenlafaxine were as follows:Cmax(101.63±29.64)vs(101.45±31.62)μg·L^(-1),AUC0-t(2694.0±834.5)vs(2702.9±946.4)μg·h·L^(-1),AUC0-∞(2753.9±885.5)vs(2753.2±988.4)μg·h·L^(-1).The 90%confidence intervals of the geometric mean ratios of Cmax,AUC0-t,AUC0-∞for the test preparation and the reference preparation were all within the equivalent interval of 80.00%-125.00%.Conclusion The test and reference preparations of hydrochloride venlafaxine extended-release tablets are bioequivalent in Chinese healthy volunteers under fed conditions.
作者 周仁鹏 吴娟 张茜 秦慧玲 吴宗好 杨士伟 鲁超 胡伟 ZHOU Ren-peng;WU Juan;ZHANG Qian;QIN Hui-ling;WU Zong-hao;YANG Shi-wei;LU Chao;HU Wei(Dept of Clinical Pharmacology, the Second Hospital of Anhui Medical University, Hefei 230601, China;Anhui Provincial Institute of Translational Medicine, Hefei 230601, China;Hefei Huafang Pharmaceutical Science & Technology Co., Ltd., Hefei 230088, China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2022年第3期411-417,共7页 Chinese Pharmacological Bulletin
基金 重大新药创制科技重大专项(No 2020ZX09201014)。
关键词 文拉法辛 O-去甲基文拉法辛 中国健康受试者 药代动力学 生物等效性 渗透泵 缓释 venlafaxine O-desmethylvenlafaxine Chinese healthy volunteers pharmacokintics bioequivalence osmotic pump extended-release
  • 相关文献

参考文献5

二级参考文献27

  • 1袁勇贵,张石宁.文拉法辛对选择性5-羟色胺再摄取抑制剂治疗无效的抑郁症患者的疗效[J].中华精神科杂志,2005,38(1):27-29. 被引量:37
  • 2IBOR JJ, CARRASCO JL, PRIETO R, et ol. Effectiveness and safety of venlafaxine extended release in elderly depressed patients[J]. Arch Gerontol Geriatr, 2008, 46(3): 317-326.
  • 3KROENKE K, MESSINA N 3RD, BENATI'IA I, et al. Venlafaxine extended release in the short- term treatment of depressed and anxious primary care patients with muhisoma- toform disorder[J]. J Clin Psychiatry, 2006, 67(1): 72-80.
  • 4WRIGHT CW, AIKMAN MS, WERTS E, et al. Bioequivalence of single and multiple doses of venlafaxine extended- release tablets and capsules in the fasted and fed states: four open- label, randomized crossover trials in healthy volunteers[J]. Clin Ther, 2009, 31 ( 11 ) : 2722-2734.
  • 5PATEL BN, SHARMA N, SANYAL M, et ol. Liquid chromato- graphy tandem mass spectrometry assay for the simultaneous determination of venlafaxine and O- desmethylvenlafaxine in human plasma and its application to a bioequivalence study[J]. J Pharm Biomed Anal, 2008, 47(3): 603-611.
  • 6TROY SM, DILEA C, MARTIN PT, et al. Bioavailability of once- daily venlafaxine extended release compared with the immediate- release formulation in healthy adult volunteers [J]. Curr Ther Res, 1997, 58(8) : 492-503.
  • 7TROY SM, PARKER VP, HICKS DR, et al. Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxine[J]. J Clin Pharmacol, 1997, 37(10): 954-961.
  • 8余勤,梁茂植,向瑾,秦永平,邹远高,南峰.盐酸文拉法辛缓释片人体药动学和生物等效性研究[J].中国新药杂志,2007,16(20):1716-1720. 被引量:8
  • 9余勤,邹静,梁茂植,南峰,秦永平,邹远高.RP-HPLC法同时测定Beagle犬血浆中曲马多、文拉法辛和罗通定浓度[J].药物分析杂志,2008,28(4):532-536. 被引量:3
  • 10张志华,何周康,周彦彬,厉宇红,田娟,左英,丁劲松.高效液相色谱-荧光法测定人血浆中文拉法辛及相对生物利用度[J].中南药学,2008,6(4):406-408. 被引量:7

共引文献60

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部